PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

IDBS takes Bioanalysis Informatics to the Cloud

Newest E-WorkBook Cloud solution strengthens IDBS’ bioanalytical domain offering
IDBS has announced the release of its next-generation bioanalytical informatics solution. Leveraging the IDBS E-WorkBook Cloud platform, the solution provides an out-of-the-box capability that enables any bioanalytical lab to take advantage of industry-standard laboratory practices.
 
By providing the required bioanalytical workflows, sample tracking, reporting and full implementation documentation (IQ/OQ) in a single packaged cloud offering, all bioanalytical laboratories will now be able to access the impressive return on investments (ROI) that come from deploying The E-WorkBook Cloud.
 
Paul Denny-Gouldson, Vice President, Strategic Solutions, IDBS said, “Our bioanalytical solution takes advantage of the most advanced technology platform that IDBS offers – simplifying scientists’ laboratory-based working whilst ensuring the highest level of compliance when working in a regulatory environment. Customers can simplify their lab informatics environments and take advantage of IDBS’ GxP cloud offering.
 
“The bioanalytical solution focuses on delivering lab efficiency gains and streamlining QA and QC using an elegant audit by exception concept that has been proven by IDBS previously. The new solution leverages E-WorkBook Inventory and other IDBS platform modules to deliver a seamless end user experience.”
 
Paul Denny-Gouldson continues: “We’re focused on making sure we support both small and the large molecule (biomolecule) bioanalysis methods – an area that historically has been poorly served but that is growing rapidly. We’ve established ourselves as a thought leader in the bioanalytical informatics space over the past 10 years and we are continuing this with our latest cloud solution. By packaging up the solution and delivering it to our customers via the cloud we can support both larger customers and smaller customers where on-premise solutions are cost and risk prohibitive.”
 
IDBS has ensured its solution meets the rigorous regulatory requirements and has already successfully delivered the bioanalytical cloud solution to its customers.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026